 | Up a level |
de Jong, Joep J; Boormans, Joost L; van Rhijn, Bas W G; Seiler, Roland; Boorjian, Stephen A; Konety, Badrinath; Bivalacqua, Trinity J; Wheeler, Thomas; Svatek, Robert S; Douglas, James; Wright, Jonathan; Dall'Era, Marc; Crabb, Simon J; Efstathiou, Jason A; van der Heijden, Michiel S; Mouw, Kent W; Miyamoto, David T; Lotan, Yair; Black, Peter C; Gibb, Ewan A; ... (2020). Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences. European urology oncology, 3(4), pp. 420-423. Elsevier 10.1016/j.euo.2020.02.010
de Jong, Joep J; Liu, Yang; Robertson, A Gordon; Seiler, Roland; Groeneveld, Clarice S; van der Heijden, Michiel S; Wright, Jonathan L; Douglas, James; Dall'Era, Marc; Crabb, Simon J; van Rhijn, Bas W G; van Kessel, Kim E M; Davicioni, Elai; Castro, Mauro A A; Lotan, Yair; Zwarthoff, Ellen C; Black, Peter C; Boormans, Joost L; Gibb, Ewan A (2019). Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. Genome medicine, 11(1), p. 60. BioMed Central 10.1186/s13073-019-0669-z
Seiler, Roland; Ashab, Hussam Al Deen; Erho, Nicholas; van Rhijn, Bas W G; Winters, Brian; Douglas, James; Van Kessel, Kim E; Fransen van de Putte, Elisabeth E; Sommerlad, Matthew; Wang, Natalie Q; Choeurng, Voleak; Gibb, Ewan A; Palmer-Aronsten, Beatrix; Lam, Lucia L; Buerki, Christine; Davicioni, Elai; Sjödahl, Gottfrid; Kardos, Jordan; Hoadley, Katherine A; Lerner, Seth P; ... (2017). Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy. European urology, 72(4), pp. 544-554. Elsevier 10.1016/j.eururo.2017.03.030
Seiler, Roland; Oo, Htoo Zarni; Tortora, Davide; Clausen, Thomas M; Wang, Chris K; Kumar, Gunjan; Pereira, Marina Ayres; Ørum-Madsen, Maj S; Agerbæk, Mette Ø; Gustavsson, Tobias; Nordmaj, Mie A; Rich, Jamie R; Lallous, Nada; Fazli, Ladan; Lee, Sherry S; Douglas, James; Todenhöfer, Tilman; Esfandnia, Shaghayegh; Battsogt, Dulguun; Babcook, John S; ... (2017). An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer. European urology, 72(1), pp. 142-150. Elsevier 10.1016/j.eururo.2017.03.021
